Abstract: HIPAA-compliant computer security method and system for recording, using a video camera, electronic visual personal health information of at least two individuals, including an individual under care, and preventing unauthorized access of the user to the video information. The video is compared to physical attribute information of the individuals stored in the computer system's memory, and the individuals are identified by facial matching. The user's stored caseload has authorization profile information including access to individuals under care. The identified individuals are compared to the user's caseload information, and the user is granted access to part of the video of the individual under care, the video of the other individuals is blurred, and the resulting video is transmitted to the user's caseload for viewing. Data fields of an information request are populated using formatted data from the video information.

Abstract: HIPAA-compliant computer security method and system for recording, using a video camera, electronic visual personal health information of at least two individuals, including an individual under care, and preventing unauthorized access of the user to the video information. The video is compared to physical attribute information of the individuals stored in the computer system's memory, and the individuals are identified by facial matching. The user's stored caseload has authorization profile information including access to individuals under care. The identified individuals are compared to the user's caseload information, and the user is granted access to part of the video of the individual under care, the video of the other individuals is blurred, and the resulting video is transmitted to the user's caseload for viewing. The video information is used to prepare automated Electronic Visit Verification (“EVV”) records.

Abstract: Disclosed are systems and methods for conducting an open conversation user interface and more particularly, to a channel-agnostic user interface experience which can utilize automated background intelligence to simplify the exchange between a software system or member service representative (MSR) and a member, and avoids the need for web-based free form inputs.

Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

Abstract: The following disclosure discusses systems and methods of detecting and analyzing cutaneous conditions. According to one embodiment, a 2D image of the cutaneous condition and a set of 3D point clouds associated with the 2D image are captured using an image capturing device. The 2D image and the set of 3D point clouds are sent to a computing device. The computing device generates a 3D surface according to the set of 3D point clouds. Subsequently, the computing device receives a depth map for the 2D image based upon the 3D surface from another computing device such that the depth map comprises depth data for each pixel of the 2D image. The cutaneous condition may then be measured and analyzed based upon the depth map using the computing device.

Abstract: The present technology relates to open respirator devices having sensors for measuring breath biometrics. For example, a respirator device (100) can include a mask component (102) that fits at least partially over a user's face and forms a gap (112) between a periphery of the mask component and the user's face, thereby forming a breathing chamber (108) between the mask portion and the user's face. A fan unit can provide air from the external environment to the breathing chamber for the user to inhale. In some embodiments, the air may be filtered before entering the breathing chamber and the fans may provide a positive pressure seal between across the gap. One or more sensors can be coupled to the mask component for measuring one or more metrics associated with the user's breath.

Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

Abstract: Disclosed are systems and methods for conducting an open conversation user interface and more particularly, to a channel-agnostic user interface experience which can utilize automated background intelligence to simplify the exchange between a software system or member service representative (MSR) and a member, and avoids the need for web-based free form inputs.

Abstract: A method for treating a gluten-induced disease, such as celiac disease, in a subject in need thereof is provided. The method comprises administering to the subject at least one agent that activates aryl hydrocarbon receptor such as AhR agonists, bacterial probiotics with AhR agonist activity, and IL-22 agonists, polypeptides and nucleic acid.

Abstract: The present technology relates to respirator devices including source control features. In some embodiments, a source control mask device can include a shield that substantially covers the mouth and nose of a user and a mechanism that can actively extract air as it is exhaled by the user. The extracted exhaled air can then be sanitized before the mask device discharges it into the atmosphere. The mask device may selectively form a seal to the user's face dependent on air flow conditions.

Abstract: The present technology relates to respirator devices including source control features. In some embodiments, a source control mask device can include a shield that substantially covers the mouth and nose of a user and a mechanism that can actively extract air as it is exhaled by the user. The extracted exhaled air can then be sanitized before the mask device discharges it into the atmosphere. The mask device may selectively form a seal to the user's face dependent on air flow conditions.

Abstract: The present technology relates to respirator devices including source control features. In some embodiments, a source control mask device can include a shield that substantially covers the mouth and nose of a user and a mechanism that can actively extract air as it is exhaled by the user. The extracted exhaled air can then be sanitized before the mask device discharges it into the atmosphere. The mask device may selectively form a seal to the user's face dependent on air flow conditions.

Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

Abstract: Disclosed are systems and methods for conducting an open conversation user interface and more particularly, to a channel-agnostic user interface experience which can utilize automated background intelligence to simplify the exchange between a software system or member service representative (MSR) and a member, and avoids the need for web-based free form inputs.

Abstract: This invention relates to methods and compositions for treating Angelman syndrome, including administering to a subject an effective amount of a clustered regularly interspersed short palindromic repeat (CRISPR)-associated endonuclease and one or more than one guide RNA molecules having complementarity to a target nucleotide sequence in UBE3A-ATS in cells of the subject.